Remeron and Desonide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Remeron (mirtazapine) and Desonide (desonide). Common drug interactions include dyskinesia among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Remeron and Desonide. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Remeron?

Remeron has active ingredients of mirtazapine. It is often used in depression. eHealthMe is studying from 26,474 Remeron users. Check the latest studies of Remeron.

What is Desonide?

Desonide has active ingredients of desonide. It is often used in rosacea. eHealthMe is studying from 5,484 Desonide users. Check the latest studies of Desonide.



On Jul, 10, 2026

11 people who take Remeron and Desonide together, and have interactions are studied.

Remeron and Desonide drug interactions.

What are the common drug interactions of Remeron and Desonide, by gender? *:

female:

  1. Dyskinesia (abnormality or impairment of voluntary movement)
  2. Dysphemia (stammering or stuttering)
  3. Limb discomfort (discomfort in leg)
  4. Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
  5. Muscle spasms (muscle contraction)
  6. Acute pulmonary oedema (sudden deposit of fluid in the lung))
  7. Alopecia (absence of hair from areas of the body)
  8. Asthenia (weakness)
  9. Blood pressure increased
  10. Cardiac disorder

male:

  1. Chronic kidney disease
  2. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  3. Constipation
  4. Depressed mood
  5. Diabetes mellitus non-insulin-dependent
  6. Diabetic cardiomyopathy (disorder of the heart muscle in people with diabetes)
  7. Drug toxicity
  8. Dysphonia (speech disorder attributable to a disorder of phonation)
  9. Dyspnoea exertional (breathlessness or shortness of breath)
  10. Fatigue (feeling of tiredness)

What are the common drug interactions of Remeron and Desonide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  2. Dyskinesia (abnormality or impairment of voluntary movement)
  3. Dysphemia (stammering or stuttering)
  4. Limb discomfort (discomfort in leg)
  5. Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
  6. Muscle spasms (muscle contraction)
  7. Asthma
  8. Drug toxicity

50-59:

  1. Apathy
  2. Blood chloride increased
  3. Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
  4. Cardiac failure congestive
  5. Chest discomfort
  6. Chest pain
  7. Constipation
  8. Depressed mood
  9. Diabetes mellitus non-insulin-dependent
  10. Diabetic cardiomyopathy (disorder of the heart muscle in people with diabetes)

60+:

  1. Chronic kidney disease
  2. Acute pulmonary oedema (sudden deposit of fluid in the lung))
  3. Oral candidiasis (fungal infection of mouth)
  4. Pain
  5. Pain in extremity
  6. Renal impairment (severely reduced kidney function)
  7. Skin lesion
  8. Stomatitis (inflammation of mucous membrane of mouth)
  9. Weight decreased
  10. Alopecia (absence of hair from areas of the body)

What are the existing conditions these people have? *

  1. High Blood Pressure: 3 people, 27.27%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 27.27%
  3. High Blood Cholesterol: 2 people, 18.18%
  4. Pain: 2 people, 18.18%
  5. Herpes Virus Infection: 2 people, 18.18%
  6. Eye Burns: 2 people, 18.18%
  7. Cardiac Disorder: 2 people, 18.18%
  8. Nausea (feeling of having an urge to vomit): 2 people, 18.18%
  9. Psoriasis (immune-mediated disease that affects the skin): 2 people, 18.18%
  10. Skin Disorder (skin disease): 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Remeron and Desonide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Remeron and Desonide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Remeron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Desonide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Remeron and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Desonide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on mirtazapine and desonide (the active ingredients of Remeron and Desonide, respectively), and Remeron and Desonide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: